Back
Impala Platinum Holdings Ltd. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
73
IMPUY
Impala Platinum Holdings Ltd.
Last Price:
$14.37
Seasonality Move:
9.95%
Sell
30
NONOF
Novo Nordisk A/S
Last Price:
$47.83
Seasonality Move:
2.46%
Buy
73
Impala Platinum Holdings Ltd. (IMPUY)
is a Buy
Is Impala Platinum Holdings Ltd. a Buy, Sell or Hold?
-
The current Impala Platinum Holdings Ltd. [IMPUY] share price is $14.37. The Score for IMPUY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
IMPUY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $47.83. The Score for NONOF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IMPUY Stock Price Chart
What is Impala Platinum Holdings Ltd.'s stock price today?
-
The Impala Platinum Holdings Ltd. share price today is $14.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMPUY is experiencing slight selling pressure.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $47.83Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
IMPUY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 72.7 | Buy |
| Chaikin Money Flow: | -107209 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.21 - 13.25) | Buy |
| Bollinger Bands (100): | (9.85 - 12.59) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 46.66 | Sell |
| Chaikin Money Flow: | -1718 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.77 - 49.23) | Sell |
| Bollinger Bands (100): | (48.12 - 57.12) | Sell |
IMPUY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.32 | Buy |
| 20-day SMA: | 12.52 | Buy |
| 50-day SMA: | 11.94 | Buy |
| 200-day SMA: | 9.32 | Buy |
| 8-day EMA: | 13.43 | Buy |
| 20-day EMA: | 12.75 | Buy |
| 50-day EMA: | 12.04 | Buy |
| 200-day EMA: | 9.81 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.56 | Sell |
| 20-day SMA: | 47.97 | Sell |
| 50-day SMA: | 50.5 | Sell |
| 200-day SMA: | 61.16 | Sell |
| 8-day EMA: | 48.66 | Sell |
| 20-day EMA: | 48.52 | Sell |
| 50-day EMA: | 50.32 | Sell |
| 200-day EMA: | 63.31 | Sell |
Impala Platinum Holdings Ltd. Earnings Growth & IMPUY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Impala Platinum Holdings Ltd. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||